| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $175,051,057 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM145225 | Conformational Energetics and Heterogeneity to Reveal Gating Mechanisms of TRPV and TRPM Ion Channels | 000 | 5 | NIH | 4/2/2026 | $404,300 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM149228 | Chemical strategies to investigate biochemical crosstalk in human chromatin | 000 | 4 | NIH | 4/7/2026 | $364,910 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM150913 | Deciphering microbial metalloenzyme functions in microaerobic host environments | 000 | 4 | NIH | 4/15/2026 | $373,652 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM151956 | DEER spectroscopy tools for probing protein conformational dynamics | 000 | 3 | NIH | 2/10/2026 | $377,238 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM152107 | Pseudomonas aeruginosa sociomicrobiology | 001 | 3 | NIH | 3/19/2026 | $38,875 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM152107 | Pseudomonas aeruginosa sociomicrobiology | 000 | 3 | NIH | 12/22/2025 | $349,875 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM152106 | New approaches for investigating the causes and consequences of cellular heterogeneity | 001 | 3 | NIH | 3/19/2026 | $58,653 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM152106 | New approaches for investigating the causes and consequences of cellular heterogeneity | 000 | 3 | NIH | 12/22/2025 | $527,871 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM162089 | Decoding cellular history in longitudinally inaccessible tissues | 000 | 1 | NIH | 2/26/2026 | $380,371 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM162070 | Biosynthesis, discovery, and biocatalytic production of halogenated nucleosides and nucleoside-sulfamates. | 000 | 1 | NIH | 3/25/2026 | $397,158 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM161276 | Mechanisms and Predictions of Interindividual Variability in Drug Pharmacokinetics and Adverse Drug Reactions | 000 | 1 | NIH | 3/20/2026 | $388,750 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM156857 | Biophysical mechanisms underlying Drosophila renal tubule morphogenesis | 001 | 2 | NIH | 3/23/2026 | $38,875 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM156857 | Biophysical mechanisms underlying Drosophila renal tubule morphogenesis | 000 | 2 | NIH | 1/13/2026 | $349,875 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM158014 | Metal catalysis in transformations of organic compounds | 000 | 2 | NIH | 5/7/2026 | $358,094 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM126942 | ncRNA: structure, function and inhibition | 000 | 9 | NIH | 5/21/2026 | $673,208 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM128752 | Complex Cell Behaviors During Epithelial Homeostasis and Stress | 000 | 8 | NIH | 4/2/2026 | $419,850 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM136218 | Bacterial quorum sensing | 000 | 7 | NIH | 4/6/2026 | $427,625 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM133428 | Investigating the landscape and genetic architecture of germline mutagenesis | 003 | 7 | NIH | 5/4/2026 | $465,348 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM136255 | Dynamics of the cellular interactome | 001 | 7 | NIH | 4/22/2026 | $485,375 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM134842 | Reconstitution and biophysical study of chromosome segregation machinery | 000 | 7 | NIH | 4/2/2026 | $727,855 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM137916 | Developing and democratizing technologies to study 3D genome organization | 001 | 7 | NIH | 4/15/2026 | $470,386 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U19AI175089 | Epithelial Immune Responses During Respiratory Viral Exacerbation of Asthma | 000 | 4 | NIH | 4/20/2026 | $1,487,760 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01DK137097 | Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes | 000 | 4 | NIH | 5/22/2026 | $816,554 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01HG011697 | Polygenic Risk Score Methods Development Consortium Coordinating Center | 002 | 5 | NIH | 5/8/2026 | $544,776 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01HG008657 | eMERGE IV Northwest: A partnership to evaluate the use of genomic information in health care | 001 | 10 | NIH | 5/8/2026 | $828,982 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01HG014603 | Population Genomics Screening Network (PGSN) Coordinating Center | 000 | 1 | NIH | 3/7/2026 | $2,114,800 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | TL1TR002318 | NRSA Training Core | 000 | 10 | NIH | 2/18/2026 | $58,867 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | TL1TR002318 | NRSA Training Core | 000 | 10 | NIH | 2/18/2026 | $947,109 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | TL1DK143270 | NRSA Training Core | 000 | 3 | NIH | 5/18/2026 | $466,384 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01CA289564 | Promotion of metastasis by apoptotic cells | 002 | 3 | NIH | 5/20/2026 | $695,856 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | T32EY007031 | Vision Training Grant | 000 | 49 | NIH | 4/2/2026 | $227,178 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | T32DA057920 | Training in Enhancing Structural Solutions in Addictions (TESSA) Program” | 000 | 4 | NIH | 5/20/2026 | $348,542 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | T32GM153507 | Molecular Biophysics Training Program | 001 | 3 | NIH | 5/4/2026 | $540,671 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | T32HL007287 | Pulmonary and Critical Care Medicine Research Training Grant | 002 | 47 | NIH | 3/25/2026 | $203,677 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U24DA058307 | HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESS | 000 | 4 | NIH | 3/27/2026 | $929,341 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U24NS100654 | University of Washington HUB Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) | 000 | 9 | NIH | 2/26/2026 | $191,519 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U24NS100654 | University of Washington HUB Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) | 000 | 9 | NIH | 2/26/2026 | $191,518 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U2CDK140919 | Northwest Comprehensive Research Training in Kidney, Urologic, and Hematologic Sciences (NCOR-KUH) | 001 | 3 | NIH | 5/15/2026 | $366,538 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01NS128537 | Next Generation Opto-GPCRs for Neuromodulatory Control | 001 | 4 | NIH | 4/21/2026 | $331,833 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01NS128537 | Next Generation Opto-GPCRs for Neuromodulatory Control | 000 | 4 | NIH | 4/7/2026 | $717,923 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | NU2GGH002242 | Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR) | 13 | 5 | CDC | 3/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 001 | 7 | NIH | 4/29/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 001 | 7 | NIH | 4/29/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 000 | 7 | NIH | 12/17/2025 | $310,800 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1AI148573 | University of Washington Vaccine and Treatment Evaluation Unit | 000 | 7 | NIH | 12/17/2025 | $887,721 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UL1TR002319 | Institute of Translational Health Sciences | 001 | 10 | NIH | 4/11/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UL1TR002319 | Institute of Translational Health Sciences | 000 | 10 | NIH | 2/13/2026 | $10,070,955 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UM1MH138543 | High-throughput and Machine Learning Optimization of Fluorescent Sensors for Multiplexed Imaging in vivo | 000 | 1 | NIH | 3/9/2026 | $2,305,031 |
| | 2026 | 2026 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | UG1DA013714 | Clinical Trials Network: Pacific Northwest Node | 003 | 25 | NIH | 2/27/2026 | $1,194,835 |
|
